Navigation Links
New Sucrets(R) ICE Cools Sore Throat Pain
Date:12/2/2008

Fruit-flavored, "frozen lozenge" provides breakthrough method to help medicine go down

LANGHORNE, Pa., Dec. 2 /PRNewswire/ -- "A spoonful of sugar helps the medicine go down" -- parents know in reality it just isn't that easy. That's why Insight Pharmaceuticals has introduced Sucrets(R) ICE -- unique, frozen single-use packages that offer cooling, soothing relief to both children's and adults' harshest sore throats.

Sucrets ICE is the newest member of the Sucrets family of products that has been trusted by doctors and moms for more than 75 years. The introduction of Sucrets ICE marks a new category in cough and cold medicines.

"Parents will no longer have to struggle with their children to get them to take their sore throat medicine or worry about the potential for choking on a traditional lozenge," said Mickael Tukdarian, vice president and general manager, Insight Pharmaceuticals. "Sucrets ICE is delivered as fruit-flavored ice -- a form that children are familiar with and enjoy."

Sucrets ICE provides relief of sore throat pain with added succulence of fruit-flavored ice. It includes the active ingredients Menthol and Pectin to act as an oral anesthetic that relieves pain and demulcent that soothes the throat. It also includes Echinacea and Zinc.

Available in grape and pomegranate flavors, each package of Sucrets ICE comes with six single-use pouches that freeze in just an hour. For adults and children 3 years of age and older, Sucrets ICE will slowly melt in their mouths, and can be repeated every two hours.

"When people are sick, they want immediate, long-lasting relief," added Tukdarian. "Sucrets ICE not only works, but also tastes great. Our motto is: 'Just freeze it and squeeze it!'"

Sucrets offers a full line of throat care products "Made Stronger to Last Longer". Whether someone has a serious sore t
'/>"/>

SOURCE Insight Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. IV Ice Slurry Quickly Cools Body for Surgeries
2. Oral Sex Implicated in Some Throat and Neck Cancers
3. Tonsillectomy Not Always Cost-Effective for Kids Throat Woes
4. Newer radiation treatment easier for some throat cancer patients
5. Integrated Beverage Group Launches Childrens Throat Cooler(R)
6. Integrated Beverage Group Launches Childrens Throat Cooler(R) in Canada
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 2Hemodynamic Therapeutics Announces Successful Completion of Initial Phase 2 Clinical Study for Novel Combination Hypertension Therapy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 2Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 3Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 4Data Published in Muscle and Nerve Validates the Six-Minute Walk Test as an Outcome Measure in Duchenne Muscular Dystrophy 5Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 1Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 2Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 3Frost 26amp 3B Sullivan Recognizes Fovia for its HDVR 28R 29 Platform A Disruptive Technology Breakthrough 6205 4Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 1Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 2Colorado MRI Clinic Blends Ultra Patient Care with Significant Cost Savings 6201 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 1Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 2Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 3Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 4Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 5Catalyst Pharmaceutical Partners Reports Third Quarter 2009 Financial Results 6197 6